Adenosine antagonist-1

CAS No. 431040-19-6

Adenosine antagonist-1( —— )

Catalog No. M32770 CAS No. 431040-19-6

Adenosine antagonist-1 acts as an adenosine A3 receptor (AA3R) antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 377 Get Quote
5MG 595 Get Quote
10MG 845 Get Quote
25MG 1187 Get Quote
50MG 1500 Get Quote
100MG 1782 Get Quote
200MG 2511 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Adenosine antagonist-1
  • Note
    Research use only, not for human use.
  • Brief Description
    Adenosine antagonist-1 acts as an adenosine A3 receptor (AA3R) antagonist.
  • Description
    Adenosine antagonist-1 is an adenosine A3 receptor (AA3R) antagonist.
  • In Vitro
    Adenosine antagonist-1 (compound 22) is an adenosine A3 receptor (AA3R) antagonist.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Adenosine Receptor
  • Recptor
    Adenosine Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    431040-19-6
  • Formula Weight
    359.41
  • Molecular Formula
    C18H13N7S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC=1N(C2=C(N=C(NC=3C=NC=CN3)S2)C4=CC(C#N)=CC=C4)C=CN1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. de Graaf C, et al. Molecular modeling of the second extracellular loop of G-protein coupled receptors and its implication on structure-based virtual screenin. Proteins. 2008 May 1;71(2):599-620.?
molnova catalog
related products
  • LUF6096

    LUF6096 (CF-602) is a potent allosteric enhancer of the adenosine A3 receptor, exhibiting the capability to enhance agonist binding allosterically while demonstrating low orthosteric affinity across adenosine receptors.

  • Selodenoson

    Selodenoson (RG-14202) is a selective adenosine A1 receptor agonist used to slow the heart rate in patients with atrial fibrillation and to treat arrhythmias.

  • Tozadenant

    A potent, selective adenosine 2A receptor (A2A/NR2B) antagonist with Ki of 11.5 nM.